Zealand Pharma A/S Aktie News & Pressemeldungen

Noticias de Eulerpool Zealand Pharma A/S

1/8/2024, 11:01:18

Heiß umkämpfter Adipositas-Markt: Pfizers Strategiedilemma

13/10/2024, 20:33:58

Alternative Ansätze für den Gewichtsverlustmarkt: Ein tieferer Einblick

24/10/2024, 17:42:29

Pharmabranche in Aufruhr: Der Kampf um den Gewichtsverlust-Markt

17/12/2024, 8:53:14

Pharma-Giganten auf Einkaufstour: Eli Lilly und Novo Nordisk planen Expansionskurs

17/12/2024, 15:54:11

Dänemark im Arbeitstakt: Novo Nordisks Einfluss auf den Arbeitsmarkt

Zealand Pharma A/S Noticias de Acciones

Zealand Pharma A/S es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Zealand Pharma A/S.

18 de junio ·
Yahoo
Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
2 de junio ·
Yahoo
Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome
27 de mayo ·
Yahoo
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
19 de mayo ·
Yahoo
Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer
16 de mayo ·
SeekingAlpha
Zealand: Promising Roche-Partnered Obesity Drug Developer - But Stock Is Pricey
12 de mayo ·
Yahoo
Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025
9 de mayo ·
SeekingAlpha
Zealand Pharma A/S (ZLDPF) Q1 2025 Earnings Call Transcript
8 de mayo ·
SeekingAlpha
Zealand Pharma A/S 2025 Q1 - Results - Earnings Call Presentation
8 de mayo ·
Yahoo
Zealand Pharma Announces Financial Results for the First Three Months of 2025
1 de mayo ·
Yahoo
Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results

Zealand Pharma A/S Noticias de la acción

Zealand Pharma A/S publica regularmente en la página web de la empresa noticias relevantes para los inversores.

Reconoce acciones infravaloradas de un vistazo.

Suscripción por 2 € / mes